ABEO: Abeona Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 201.33
Enterprise Value ($M) 186.86
Book Value ($M) 14.83
Book Value / Share 0.54
Price / Book 13.58
NCAV ($M) 6.56
NCAV / Share 0.24
Price / NCAV 30.69

Profitability (mra)
Return on Invested Capital (ROIC) -2.68
Return on Assets (ROA) -0.84
Return on Equity (ROE) -2.02

Liquidity (mrq)
Quick Ratio 4.15
Current Ratio 4.15

Balance Sheet (mrq) ($M)
Current Assets 55.74
Assets 64.00
Liabilities 49.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.50
Operating Income -48.20
Net Income -54.19
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -37.01
Cash from Investing 0.21
Cash from Financing 37.06

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A EcoR1 Capital, LLC 4.20 -39.13
02-14 13G/A Armistice Capital, Llc 4.99 17.64
02-14 13G/A Point72 Asset Management, L.P. 6.40 43.37
02-14 13G/A Nantahala Capital Management, LLC 9.90 83.85
02-12 13G/A Flynn James E 3.39 -50.00
01-10 13G/A Integrated Core Strategies (us) Llc 5.70 4.15
07-06 13G/A Adage Capital Partners Gp, L.l.c. 15.32 144.15

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-04-10 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1)
2023-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 40,987 127,763 32.08
2024-03-26 49,130 198,622 24.74
2024-03-25 39,578 167,610 23.61
2024-03-22 27,040 171,596 15.76

(click for more detail)

Similar Companies
AADI – Aadi Bioscience, Inc. ABIO – ARCA biopharma, Inc.
ABVC – ABVC BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Abeona Therapeutics